Assignee
SML BIOPHARM CO LTD
KR·1 granted patent·2 pending applications·0 citations·filing 2022–2022
Top patents by PatentIndex Score
3 records- 0154US2025064985A1Nucleic acid expression platform with increased expression efficiencySML BIOPHARM CO LTD·Filed 2022·Application pending·0 cites
- 0251US2024374707A1Expression system and nucleic acid-based pharmaceutical composition comprising sameSML BIOPHARM CO LTD·Filed 2022·Application pending·0 cites
- 0350US12414918B2Pharmaceutical composition of lipid nanoparticle for delivering nucleic acid drug containing trehalose derivative and novel structure-maintaining lipid compoundSML BIOPHARM CO LTD·Filed 2022·Granted Sep 16, 2025·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when SML BIOPHARM CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →